Phase 1 Center - Developmental Therapeutics and Gene Therapy


To support higher-need clinical trials, the CTSI has established a dedicated Phase 1 Center for studies as well as gene and cellular therapy trials. Among the highlighted services, the center provides:

  • A core facility with IBC
  • Special rates
  • Tailored services (information coming soon!)
  • Research nurses and medical assistants with additional education and certifications in biosafety level 2, gene therapies and cellular therapies
  • Expanded access hours, evenings, weekends and overnight stays to accommodate intensive pharmacokinetic sampling
  • Mobile research services for those subjects that require inpatient hospitalization
  • A dedicated study activation team provides navigation through the complexity of assessing feasibility, budgeting, coverage analysis and regulatory compliance

Related Resources and Processes